Impact of Immunosuppressive Treatment on Liver Fibrosis in Autoimmune Hepatitis
- 1 March 2005
- journal article
- research article
- Published by Springer Science and Business Media LLC in Digestive Diseases and Sciences
- Vol. 50 (3), 547-551
- https://doi.org/10.1007/s10620-005-2472-5
Abstract
No abstract availableKeywords
This publication has 11 references indexed in Scilit:
- Decreased fibrosis during corticosteroid therapy of autoimmune hepatitisJournal of Hepatology, 2004
- A simple noninvasive index can predict both significant fibrosis and cirrhosis in patients with chronic hepatitis CHepatology, 2003
- Rating fibrosis progression in chronic liver diseasesJournal of Hepatology, 2003
- Long-term treatment of patients affected by systemic sclerosis with cyclosporin ARheumatology, 2001
- Treatment of idiopathic retroperitoneal fibrosis using cyclosporinAnnals Of The Rheumatic Diseases, 2001
- Regression of Liver Fibrosis after Biliary Drainage in Patients with Chronic Pancreatitis and Stenosis of the Common Bile DuctThe New England Journal of Medicine, 2001
- Cyclosporin A is a promising alternative to corticosteroids in autoimmune hepatitis.Digestive Diseases and Sciences, 2001
- Impact of Interferon Alfa-2b and Ribavirin on Progression of Liver Fibrosis in Patients With Chronic Hepatitis CHepatology, 2000
- Reversibility of Hepatic Fibrosis in Autoimmune HepatitisAnnals of Internal Medicine, 1997
- Histological grading and staging of chronic hepatitisJournal of Hepatology, 1995